Keyword: Excipact

News

EXCiPACT to Extend Postponement Interval for Audits

24.03.2020 - Developments in the battle against COVID-19 have intensified rapidly. Recent epidemiological data has indicated the fight will last for some considerable time, especially in Europe...

Plant Construction & Process Technology

The EXCiPACT Certification Scheme

27.09.2017 - There is a regulatory expectation that pharmaceutical companies will verify that the excipients produced by their suppliers are to an appropriate level of GMP. This has been...

News

Roquette Receives EXCiPACT Certification

11.04.2016 - Roquette has recently obtained EXCiPACT certification from SGS France, one of the international auditors authorized to grant approval under this standard. The certificate...

Plant Construction & Process Technology

The EXCiPACT Certification Scheme

05.10.2014 - Excipients, together with an active pharmaceutical ingredient (API), are formulated into a final drug that is either prescribed to a patient by a doctor or bought over-the-counter...

News

Driving Innovation in the Supply Chain

29.01.2013 - The European chemical distribution industry has constantly been an example of unity, as the work of the European Association of Chemical Distributors (Fecc) shows, working together...

News

EXCiPACT Signs Agreements Cbs for Certification of Pharmaceutical Excipient Suppliers

29.11.2012 - The EXCiPACT Association - a project of the IPEC Federation - is pleased to announce that it has completed Framework Agreements with two internationally-recognised Certification...

News

Fecc’s Members are Top Priority

14.05.2012 - One For All - An efficient chemical distribution sector plays a key role in enhancing the competitiveness of the chemicals industry. The European Association of Chemical...

News

The EFCG is Pushing Its Agenda Forward During Complex Times

14.04.2011 - Tony Scott credits Hovione CEO Guy Villax with coining the phrase, "saints and sinners" when referring to the notoriously uneven playing field in the world of API and excipient...